Rudolf H. Moos, PhD
Articles
November 30th 2015
Anticoagulation in Atrial Fibrillation: Impact of Mental Illness
Susan K. Schmitt, PhD Mintu P. Turakhia, MD, MAS Ciaran S. Phibbs, PhD Rudolf H. Moos, PhD Dan Berlowitz, MD, MPH Paul Heidenreich, MD, MS Victor Y. Chiu, MD Alan S. Go, MD Sarah A. Friedman, MSPH Claire T. Than, MPH Susan M. Frayne, MD, MPH
Atrial fibrillation patients with mental health conditions are less likely to be eligible for warfarin receipt, and those who are eligible receive warfarin at lower rates.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 10th 2024 | Updated: January 22nd 2025
Genetic Links to High Altitude Found to Reduce Inflammation, Speed Response to PV Therapy
